Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Staff profiles  /  
  • Dr Sandra Prior

Dr Sandra Prior

Sandra joined NIBSC in 2015 as a Senior Scientist. She has over 15 years’ experience in applied immunology and the development of in vitro cell-based bioassays and immunoassays for both biotherapeutics and vaccines.

Sandra studied in the University of Navarra, Pamplona, Spain where she received her Ph.D. working in collaboration with the Federal Institute for Technology (ETH) in Zurich, Switzerland. She worked as a post-doctoral scientist at NIBSC evaluating the toxicological and immunological properties of recombinant toxin constructs as vaccine candidates and later investigating the safety and protective mechanisms of combination bacterial vaccines.

In 2010, she joined Lonza Biologics Applied Protein Services in Cambridge, U.K. where she worked on bioassay development as well as preclinical and clinical in vitro immunogenicity assessment of a wide portfolio of biological products and targets
. Her role included leading customer-orientated and technical development projects within multidisciplinary teams.

Sandra is currently working on the development of bioassay standards for therapeutic Monoclonal Antibodies (mAbs). She is also involved in a number of research projects investigating structure-function relationships in the context of safety and efficacy of biotherapeutic mAbs, with an interest in biosimilars.

Current position

Senior Scientist, Molecular Immunology, Division of Biotherapeutics

Areas of interest

Monoclonal antibodies
Standardization of Biologicals
Biosimilars
Bioassay development
Antibody Fc-effector functions
Immunogenicity of Biotherapeutics

Qualifications

2000: PhD. in Natural Sciences (Hons), University of Navarra, Spain. Collaboration with Federal Institute for Technology Zurich (ETH), Switzerland

1995: Licentiate in Pharmacy, University of Navarra, Spain


Representation on external committees and focused groups

Member of the European Directorate for the Quality of Medicinies (EDQM) Monoclonal antibodies working party expert committee (MAB WP)

Member of the Immune Mitigation Action Programming Area (IMAPA) within the Therapeutic Product Immunogenicity focus Group (TPIFG), AAPS Biotechnology section.

Publications (PDF, 99KB)

  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap